Net profit of Marksans Pharma rose 8.26% to Rs 113.20 crore in the quarter ended December 2025 as against Rs 104.56 crore during the previous quarter ended December 2024. Sales rose 10.64% to Rs 754.43 crore in the quarter ended December 2025 as against Rs 681.85 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 754.43 | 681.85 | 11 |
| OPM % | 21.31 | 20.35 | - |
| PBDT | 174.95 | 163.95 | 7 |
| PBT | 150.62 | 143.26 | 5 |
| NP | 113.20 | 104.56 | 8 |